The Na+-D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference271 articles.
1. Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus;Abdul-Ghani;Am J Physiol Renal Physiol,2015
2. Functional characterization of mouse/glucose transporter type 3b;Aljure;Am J Physiol Cell Physiol,2010
3. Revised immunolocalization of the Na+-D-glucose cotransporter SGLT1 in rat organs with an improved antibody;Balen;Am J Physiol Cell Physiol,2008
4. NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1;Balteau;Cardiovasc Res,2011
5. SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states;Banerjee;Cardiovasc Res,2009
Cited by 115 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Atrial fibrillation in cancer, anticancer therapies, and underlying mechanisms;Journal of Molecular and Cellular Cardiology;2024-09
2. Pharmacological targets of SGLT2 inhibition on prostate cancer mediated by circulating metabolites: a drug-target Mendelian randomization study;Frontiers in Pharmacology;2024-08-06
3. Development of a selective novel fluorescent substrate for sodium-dependent transporters;Life Sciences;2024-08
4. Empagliflozin demonstrates cytotoxicity and synergy with tamoxifen in ER-positive breast cancer cells: anti-proliferative and anti-survival effects;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-07-27
5. Empagliflozin and dapagliflozin decreased atrial monoamine oxidase expression and alleviated oxidative stress in overweight non-diabetic cardiac patients;Molecular and Cellular Biochemistry;2024-07-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3